United States
                  Environmental Protection
                  Agency
 Health Effects
 Research Laboratory
 Research Triangle Park NC 27711
                  Research and Development
 EPA/600/S1-87/010  Jan. 1988
oEPA         Project  Summary
                   Effects  of 4,4'-Methylene-bis-
                   (2-Chloroaniline)  and
                   Benzotrichloride  in
                   Human  and/or Animal Tissues
                  Gary D. Stoner, Herman A. J. Schut, Narayan Shivapurkar, and
                  In-Chang Hsu
                                                                                  '/
                                                                                   *f-
                    4.4'-Methylene-bis-(2-chloroaniline)
                  (MOCA) is an aromatic amine with
                  structural similarity to known human
                  bladder carcinogens, and induces
                  urothelial tumors in dogs. In this study
                  the binding to DNA and DNA-adduct
                  formation of MOCA in explant cultures
                  of human and dog bladder was
                  compared. The ability of MOCA to bind
                  to DNA in both human and dog bladder
                  explants was related  to the dose of
                  MOCA. In both species, there appeared
                  to be a population  with high DNA
                  binding activity and another with low
                  DNA binding  activity. Preliminary
                  studies using  the 32P-postlabeling
                  technique showed that several MOCA-
                  DNA adducts were  formed in both
                  human and dog bladder with at least
                  three adducts in common between the
                  two species. These results indicate the
                  potential of MOCA to induce genetic
                  damage in human bladder and suggest
                  caution in the occupational exposure of
                  humans to this chemical.
                    Benzotrichloride (BTC) is used in the
                  synthesis of  benzoyl chloride and
                  benzoyl peroxide, and epidemioJogical
                  data suggest that BTC is a human lung
                  carcinogen. In this project, BTC was
                  evaluated for its ability to induce lung
                  adenomas in strain A/J mice. Four
                  groups of male and female A/J mice
                  were injected i.p. with either tricaprylin
                  or BTC in tricaprylin three times a week
                  for 8  weeks. BTC groups received
                  doses totaling  1440 mg/kg, 719
                  mg/kg,  or 287 mg/kg. The mean
                  number of lung tumors per mouse was
127.87 ± 5.81, 43 ± 2.44, and 17.73
± 1.09 in the groups treated with either
1440 mg/kg, 719 mg/kg, or 287 mg/
kg,  respectively. Tricaprylin-vehicle
controls had a mean number of 0.46
± 0.15 lung tumors per mouse. There-
fore, BTC  produced a  significant
(p<0.001) and dose-related increase in
the lung tumor response  when com-
pared to tricaprylin controls, and is a
potent carcinogen in the strain A mouse
lung tumor bioassay. These results
suggest caution  in the exposure of
humans to BTC.
  This Project Summary  was  devel-
oped by EPA's Health Effects Research
Laboratory, Research Triangle Park.
NC, to announce key findings  of the
research  project  that is  fully
documented in a separate report of the
same title (see Project Report ordering
information at back).

Introduction

4,4 '-Methylene-bis-(2-
Chloroaniline) (MOCA)
  MOCA, a commerically important
curing agent in  the manufacture  of
polyurethane, is an aromatic amine with
structural similarity  to known human
bladder carcinogens. It induces lung and
liver tumors in mice and rats and bladder
tumors in dogs. In addition, MOCA is
mutagenic in the Salmonella typhimu-
rium mutagenesis (Ames) assay, geno-
toxic in mouse and reta hepatocytes, and
positive in mammalian cell transforma-
tion assays. Human exposure to MOCA

-------
occurs during its manufacture and use.
Also, families of workers involved in the
manufacture of MOCA and residents  in
the area of manufacturing plants are
exposed to MOCA  as  indicated by the
presence of MOCA in  their urine. Evi-
dence of its mutagenic  and carcinogenic
activity in  experimental systems and  of
human exposure to MOCA suggests the
importance of determining its genotoxic
potential in humans and especially  in the
bladder.

  Tissues  from several human and
animal organs, including the bladder, can
be maintained as explants in serum-free
medium. Explant cultures of human and
animal  tissues  have been  used exten-
sively for comparisons of the metabolism,
DMA-binding and DNA-adduct formation
of a wide variety of chemical carcino-
gens, including certain aromatic amines.
In general, these studies have demon-
strated  that the metabolism of carcino-
gens and the profile of carcinogen-DNA
adducts in human  tissues  is similar to
that in  animal model  tissues in which
the carcinogen has been shown to induce
cancer. Most differences in metabolism
between humans and animals have been
quantitative rather than qualitative.

  In this study, explant cultures  were
used to compare the ability of MOCA to
induce  genetic damage  in cultured
explants of human and dog bladder. The
results  indicate that  MOCA induces
levels  of  genetic  damage in Jiuman
bladder that are similar to  those in the
dog, a species in which MOCA has been
shown  to  induce urothelial cancer.
Therefore, MOCA could represent a
significant risk to exposed individuals.

Benzotrichloride (BTC)
  BTC is used exclusively as a chemical
intermediate. The most important  deriv-
ative of BTC is benzoyl  chloride,  an
intermediate in the  manufacture  of
several dyes,  pigments,  herbicides,
Pharmaceuticals, and antimicrobial
agents. BTC does not occur naturally in
the environment; however,  it has been
found in surface waters. BTC is unstable
in the environment and hydrolyzes  to
benzoic acid and hydrochloric acid in the
presence of moisture.
  Epidemiological  studies  indicate  an
increase in the incidence of lung cancer
among  workers  in Japanese chemical
plants using BTC and other chemicals in
the manufacture of benzoyl chloride and
benzoyl peroxide.
  Toxicity studies indicate that BTC is a
skin, eye  and respiratory irritant. In
addition, BTC is mutagenic in \beBacillus
subtilus-rec assay, and in  both the
Escherichia coli and Salmonella typhi-
murium (Ames test) reversion assays
  Benzotrichloride has induced tumors
in experimental  animals.  Intragastric
doses  of BTC produced forestomach
cancers (squamous cell carcinomas) and
lung cancers (adenomas and carcino-
mas) in female  ICR mice.  In a skin
painting study  in female  ICR mice, BTC
induced skin tumors, lymphomas, lung
tumors, and tumors of the  lips, tongue
and forestomach.
  The strain A mouse lung tumor bioas-
say is a short-term quantitative bioassay
for carcinogens The bioassay has been
utilized for the testing of  more than 300
environmental chemicals for carcino-
genic activity. In  this study, BTC was
tested  for  its ability to induce lung
adenomas  in  strain A  mice  and its
potency was compared to that of other
carcinogens. The data indicate that BTC
is a strong carcinogen in the strain A
mouse lung tumor bioassay,  and could
represent  a significant risk to exposed
individuals.

Discussion

MOCA Studies
  The  aromatic  amines,  lilke  many
organic carcinogens, are not  direct-
acting  genotoxins. It is thought that they
are metabolized and conjugated predom-
inately in the  liver and excreted in the
urine, where under mildly acidic condi-
tions,  hydrolysis of  the  conjugates
occurs. The resulting free active metab-
olites  may  then decompose to form
electrophiles that react with DNA in the
bladder epithelium.
   Recent studies have shown however,
that the bladder  epithelium itself is
capable of  metabolizing carcinogens,
including  2-acetylaminofluorene, to
genotoxic electrophiles. Moreover, in the
present study, it was  shown that both
human and dog bladder  urothelium are
capable  of metabolizing  MOCA  mto
forms that induce DNA damage. The data
indicate that the binding of MOCA to
human bladder DNA is higher than in the
dog bladder. This result is of particular
importance since MOCA has been shown
to induce urothelial cancer in dogs.  The
data also show a wide variation among
both humans  and dogs  in the levels of
binding of MOCA metabolites to bladder
DNA. This observation is consistent with
previous results in which there was a
wide variation in the binding of carcin-
ogens  to  human  and  animal  bladder
DNA. It has been suggested that differ-
ences among individuals in their ability
to metabolize carcinogens into forms that
bind to DNA  might be associated with
carcinogenic risk. It this were the case,
then some individuals exposed to MOCA
may be more likely  to develop bladder
cancer than others
  Although the studies on the detection
of  MOCA-DNA adducts using  32P-
postlabeling assay are quite preliminary,
the data  show formation  of  several
adducts in the dog  as well as in  the
human. There appear to be at least two
adducts in common between the dog and
the human. The observed qualitative and
quantitative differences in the number of
adducts detected  in different samples
could be due to the low levels of adducts
formed.  These  studies need to be
expanded to  include  more samples
before any conclusions can be drawn. In
another set of preliminary studies, when
deoxynucleoside hydrolysates  of DNA
from two different [3H]MOCA-treated dog
bladder samples  and human  bladder
samples were subjected to high perfor-
mance liquid chromatography  (h.p I c )
analysis, there was evidence  for several
adducts with at least four  adducts in
common  between  the dog and  the
human.
  In this  project, the metabolites of
MOCA produced mto the culture medium
were  not  identified. Recent  studies by
others suggest that MOCA is metabolized
by  both   N-hydroxylation  and  C-
hydroxylation pathways. In addition, the
precise chemical nature of the adducts
formed between MOCA and bladder DNA
was not determined.  Studies  are in
progress to identify  the  MOCA metab-
olites and MOCA-DNA adducts in order
to develop a complete  understanding of
MOCA metabolism and the  mechanism
of MOCA-induced DNA damage Never-
theless, our results  clearly indicate the
potential of MOCA to induce genetic
damage  in  the human bladder and
suggest  caution  in the occupational
exposure of humans to this chemical.

Benzotrichloride Studies
  Although  BTC  has  been  shown to
induce tumors in experimental animals,
it was  decided to evaluate the potential
carcinogenic activity of BTC m the strain
A mouse  lung tumor  bioassay and to
compare its tumongenic potency  with
that of other known carcinogens. Results

-------
 ndicate that BTC induces a high occur-
rence of lung  adenomas in  A/J mice
within 6 months after initial i.p. adminis-
tration. The tumorigenic response to BTC
is dose-related. The tumors exhibited the
morphology of the mouse lung adenoma
as previously described. Since lung
carcinomas occur rarely in strain A mice,
and usually are not seen until 1-1.5 years
after carcinogen administration, it was
not surprising that carcinomas were not
observed within the 6-month period of
the BTC bioassay.
  At the MTD, approximately 58 jumol/kg
of BTC was required to induce an average
of one lung tumor per mouse.  Therefore,
BTC is  approximately one-half as active
as benzo(a)pyrene and seven times more
active than urethan as an inducer of lung
tumors in strain A mice. However, these
comparisons  of  carcinogenic  potency
could be misleading since several of the
carcinogens were administered  in  a
single dose  and BTC was  given  in
multiple  doses.  Nevertheless,  in  the
authors'  experience with urethan, the
latency period for lung tumor develop-
ment is  shorter  and the  number  of
induced  tumors  is higher when  the
compound  is administered  in a single
high dose injection than when that same
dose  is  fractionated  in 24 injections
administered during an 8-week period.
If this is  true for the other carcinogens
that were given in a single injection, then
the relative potency of BTC could actually
be underestimated.
  Results from the strain A mouse lung
tumor  bioassay,  comparing  BTC  with
other known carcinogens, coupled with
the epidemiological, mutagenicity and
other carcinogenicity data, suggest that
exposure to BTC may represent a signif-
icant carcinogenic risk  to man.
Conclusions
  1.
     MOCA induces genetic damage in
     explant cultures of human uroth-
     elium and could present a risk for
     bladder carcinogenesis in exposed
     individuals.
 2.
     BTC is a carcinogen in the strain
     A/J mouse  lung  tumor bioassay
     and could present a risk for  lung
     cancer in exposed individuals.
Recommendations
  On the basis of previous epidemiolog-
ical and experimental investigations, and
on the results of the present studies, the
authors  recommend  caution in the
occupational exposure of humans to both
4,4'-methylene-bis-(2-chloroaniline)and
benzotrichloride.
  G. D. Stoner, H. A. J. Schut, and N. Shivapurkar are with the Medical College
    of Ohio, Toledo, OH 43614; and I-C. Hsu is with the University of Maryland,
    Baltimore, MD212O1.
  MarcJ. Mass is the EPA Project Officer (see below).
  The  complete report, entitled "Effects of 4,4'-Methylene-bis-(2-Chloroanilinel
    and Benzotrichloride in Human and/or Animal Tissues," (Order No. PB 88-
    117 882/AS; Cost: $12.95, subject to change) will be available only from:
          National Technical Information Service
          5285 Port Royal Road
          Springfield, VA 22161
          Telephone: 703-487-4650
  The EPA Project Officer can be contacted at:
          Health Effects Research Laboratory
          U.S. Environmental Protection Agency
          Research Triangle Park, NC 27711

-------
United States
Environmental Protection
Agency
Center for Environmental Research
Information
Cincinnati OH 45268
                                                                                                       ^sJooirn   7  ?
                                                                                                    /, 7 '.'El
Official Business
Penalty for Private Use S300

EPA/600/S1-87/010
                                                                   6250I&9 t
               0000329   PS

-------